VRAX – virax biolabs group limited - ordinary shares (US:NASDAQ)
Stock Stats
News
Virax Biolabs Group (NASDAQ:VRAX) was upgraded by analysts at Zacks Research to a "hold" rating.
Virax Biolabs Group (NASDAQ:VRAX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Virax Biolabs Group (NASDAQ:VRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock, down previously from $3.00.
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement [Yahoo! Finance]
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Form 424B3 Virax Biolabs Group Ltd
Form EFFECT Virax Biolabs Group Ltd
Form F-3 Virax Biolabs Group Ltd
Form D Virax Biolabs Group Ltd
Form 6-K Virax Biolabs Group Ltd For: Dec 04
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.